1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Brain Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cossu, F; Melis, G; Rombi, G | 1 |
1 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Brain Neoplasms
Article | Year |
---|---|
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |